journal cover

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

Annals of the Rheumatic Diseases

Apr 1, 2011

Moetaza M SolimanBritish Society for Rheumatology Biologics Register

Get paper from

Abstract

To evaluate the effect of different concomitant disease modifying antirheumatic drugs (DMARDs) on the persistence with antitumour necrosis factor (anti-TNF) therapies in patients with rheumatoid arthritis (RA). This analysis included 10 396 patients with RA registered with the British S...read more

Mentioned in this Paper

Leflunomide
Biological Products
Proportional Hazards Models
Etanercept
Polychemotherapy
Rheumatology Specialty
Erythrityl Tetranitrate
Subgroup A Nepoviruses
Hydroxychloroquine
Methotrexate, (DL)-Isomer
1
82
Paper Details
References
  • References27
  • Citations82
123
  • References27
  • Citations82
12345...

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

Annals of the Rheumatic Diseases

Apr 1, 2011

Moetaza M SolimanBritish Society for Rheumatology Biologics Register

PMID: 21330639

DOI: 10.1136/ard.2010.139774

Abstract

To evaluate the effect of different concomitant disease modifying antirheumatic drugs (DMARDs) on the persistence with antitumour necrosis factor (anti-TNF) therapies in patients with rheumatoid arthritis (RA). This analysis included 10 396 patients with RA registered with the British S...read more

Mentioned in this Paper

Leflunomide
Biological Products
Proportional Hazards Models
Etanercept
Polychemotherapy
1
82

Related Papers

Paper Details
References
  • References27
  • Citations82
123
  • References27
  • Citations82
12345...

Get paper from

/papers/impact-of-concomitant-use-of-dmards-on-the/21330639